Skip to main content

Table 2 Clinicopathological features and CBC index of esophageal squamous cell carcinoma

From: The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma

characteristic

Training cohort(n = 1228)

Validation cohort(n = 359)

Number of patients

Composition ratio (%)

Number of patients

Composition ratio (%)

Sex

 Male

845

68.8%

258

71.9%

 Female

383

31.2%

101

28.1%

Age

  < 60 years

415

33.8%

111

30.9%

  ≥ 60 years

813

66.2%

248

69.1%

NLR

  < 3.29

864

70.4%

252

70.2%%

  ≥ 3.29

364

29.6%

107

29.8%%

NMR

  < 12.77

1013

82.5%

289

80.5%

  ≥ 12.77

215

17.5%

70

19.5%

LMR

  < 2.95

421

34.3%

126

35.1%

  ≥ 2.95

807

65.7%

233

64.9%

RDW

  < 15.05%

786

64%

234

65.2%

  ≥ 15.05%

442

36%

125

34.8%

PDW

  < 13.65%

1103

89.8%

324

90.3%

  ≥ 13.65%

125

10.2%

35

9.7%

Tumor location

 Upper

49

4.0%

12

3.3%

 Middle

892

72.6%

258

71.9%

 Lower

287

23.4%

89

24.8%

Depth of tumor invasion

 pT1

106

8.6%

27

7.5%

 pT2

301

24.5%

87

24.2%

 pT3

793

64.6%

230

64.1%

 pT4

28

2.3%

15

4.2%

Lymph node metastasis

 pN0

502

40.9%

149

41.5%

 pN1

502

40.9%

134

37.3%

 pN2

224

18.2%

76

21.2%

Differentiation

 G1

61

5%

15

4.2%

 G2

693

56.4%

210

58.5%

 G3

474

38.6%

134

37.3%

Stage

 I

98

8%

27

7.5%

 II

506

41.2%

141

39.3%

 III

624

50.8%

191

53.2%

  1. NOTE:NLR:neutrophil to lymphocyte ratio;NMR:neutrophil to monocyte ratio;LMR:lymphocyte to monocyte ratio;RDW: red blood cell distribution width;PDW: blood cell distribution width;HR: hazard ratio; CI: confidence interval